Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study (Q44849439)
scientific article published in April 2004
Language:
(P31) (Q13442814)
(P50) (Q39793026)
(Q47006550)
(Q85134698)
(P304) 1253-1263
(P407) (Q1860)
(P433) 9417
(P478) 363
(P577) Thursday, April 1, 2004
(P921) (Q422645)
(Q423984)
(Q263713)
(Q422631)
(P1433) (Q939416)
(P1476) "Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study" (language: en)
(P2093) F van Leth
P Phanuphak
K Ruxrungtham
E Baraldi
S Miller
B Gazzard
P Cahn
U G Lalloo
I P van der Westhuizen
D R Malan
M A Johnson
B R Santos
F Mulcahy
R Wood
G C Levi
G Reboredo
K Squires
I Cassetti
D Petit
F Raffi
J P Dam
E Hassink
R van Leeuwen
P Robinson
F W Wit
J M A Lange
2NN Study team
(P2860) (Q44088437)
(Q34191241)
(Q34120588)
(Q74239445)
(Q43945659)
(Q44108848)
(Q43820991)
(Q34108631)
(Q43634105)
(Q43646768)
(Q43702175)
(Q43752431)
(Q56791553)
(Q73687836)
(Q74836115)
(Q34658632)
(Q33998014)
(Q43902376)
(Q34314152)
(Q69492810)
(Q35184553)
(Q45944350)
(Q34464169)
(Q45751686)
(Q42627921)
(Q45789390)
(Q43851688)
(Q45739024)
other details
description scientific article published in April 2004

External Links